Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Nemours Children's Clinic - Jacksonville
mi
from
Jacksonville, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Nemours Children's Clinic - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Miami Miller School of Medicine-Sylvester Cancer Center
mi
from
Miami, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Miami Miller School of Medicine-Sylvester Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Florida Hospital
mi
from
Orlando, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
UF Cancer Center at Orlando Health
mi
from
Orlando, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
UF Cancer Center at Orlando Health
mi
from
Orlando, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Nemours Children's Hospital
mi
from
Orlando, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Nemours Children's Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
All Children's Hospital
mi
from
Saint Petersburg, FL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Chicago
mi
from
Chicago, IL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Advocate Children's Hospital Oak Lawn
mi
from
Oak Lawn, IL
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Advocate Children's Hospital Oak Lawn
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Indiana University Medical Center
mi
from
Indianapolis, IN
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Blank Children's Hospital
mi
from
Des Moines, IA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Blank Children's Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Ochsner Medical Center Jefferson
mi
from
New Orleans, LA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Ochsner Medical Center Jefferson
mi
from
New Orleans, LA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Baystate Medical Center
mi
from
Springfield, MA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Michigan State University Clinical Center
mi
from
East Lansing, MI
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Michigan State University Clinical Center
mi
from
East Lansing, MI
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Beaumont Children's Hospital-Royal Oak
mi
from
Royal Oak, MI
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Beaumont Children's Hospital-Royal Oak
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Columbia Regional
mi
from
Columbia, MO
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Columbia Regional
mi
from
Columbia, MO
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of New Mexico
mi
from
Albuquerque, NM
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Albany Medical Center
mi
from
Albany, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Mission Hospital-Memorial Campus
mi
from
Asheville, NC
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Mission Hospital-Memorial Campus
mi
from
Asheville, NC
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Hospital Medical Center of Akron
mi
from
Akron, OH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Hospital Medical Center of Akron
mi
from
Akron, OH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Dayton Children's Hospital
mi
from
Dayton, OH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Dayton Children's Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Natalie Warren Bryant Cancer Center at Saint Francis
mi
from
Tulsa, OK
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Natalie Warren Bryant Cancer Center at Saint Francis
mi
from
Tulsa, OK
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Oncology Group
mi
from
Philadelphia, PA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Oncology Group
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Greenville Cancer Treatment Center
mi
from
Greenville, SC
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Greenville Cancer Treatment Center
mi
from
Greenville, SC
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Primary Children's Hospital
mi
from
Salt Lake City, UT
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
West Virginia University Charleston
mi
from
Charleston, WV
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
West Virginia University Charleston
mi
from
Charleston, WV
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Marshfield Clinic
mi
from
Marshfield, WI
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Sydney Children's Hospital
mi
from
Randwick,
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Sydney Children's Hospital
mi
from
Randwick,
Click here to add this to my saved trials
Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
A Randomized, Open-Label, Dose Escalation Study of Bevacizumab With Ambulatory Blood Pressure Monitoring in Previously Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/18/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
A Randomized, Open-Label, Dose Escalation Study of Bevacizumab With Ambulatory Blood Pressure Monitoring in Previously Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/18/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
A Randomized, Open-Label, Dose Escalation Study of Bevacizumab With Ambulatory Blood Pressure Monitoring in Previously Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/18/2016
North Shore University Health System
mi
from
Evanston, IL
Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
A Randomized, Open-Label, Dose Escalation Study of Bevacizumab With Ambulatory Blood Pressure Monitoring in Previously Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/18/2016
North Shore University Health System
mi
from
Evanston, IL
Click here to add this to my saved trials
Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
A Randomized, Open-Label, Dose Escalation Study of Bevacizumab With Ambulatory Blood Pressure Monitoring in Previously Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/18/2016
Ingalls Memorial Hospital
mi
from
Harvey, IL
Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
A Randomized, Open-Label, Dose Escalation Study of Bevacizumab With Ambulatory Blood Pressure Monitoring in Previously Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/18/2016
Ingalls Memorial Hospital
mi
from
Harvey, IL
Click here to add this to my saved trials
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Phase I Randomized, Placebo-Controlled, Cross-Over, Dose-Finding Pharmacokinetic Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Status: Enrolling
Updated:  5/19/2016
Columbia University Medical Center
mi
from
New York, NY
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Phase I Randomized, Placebo-Controlled, Cross-Over, Dose-Finding Pharmacokinetic Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Status: Enrolling
Updated: 5/19/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Cocinar Para su Salud! (Cook for Your Life!)
Cocinar Para su Salud! (Cook for Your Life!): Implementing Dietary Change Among Hispanic Breast Cancer Survivors
Status: Enrolling
Updated:  5/19/2016
Columbia University Medical Center
mi
from
New York, NY
Cocinar Para su Salud! (Cook for Your Life!)
Cocinar Para su Salud! (Cook for Your Life!): Implementing Dietary Change Among Hispanic Breast Cancer Survivors
Status: Enrolling
Updated: 5/19/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer
Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer
Status: Enrolling
Updated:  5/19/2016
University of Vermont Medical Center
mi
from
Burlington, VT
Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer
Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer
Status: Enrolling
Updated: 5/19/2016
University of Vermont Medical Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
A Phase Ib/II Study of BGJ398 in Combination Modified FOLFIRINOX in Treatment-Naïve Metastatic Pancreatic Cancer Patients
Status: Enrolling
Updated:  5/19/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
A Phase Ib/II Study of BGJ398 in Combination Modified FOLFIRINOX in Treatment-Naïve Metastatic Pancreatic Cancer Patients
Status: Enrolling
Updated: 5/19/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors
Phase I Dose-Escalation Drug-Interaction Study of Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors
Status: Enrolling
Updated:  5/19/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors
Phase I Dose-Escalation Drug-Interaction Study of Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors
Status: Enrolling
Updated: 5/19/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Status: Enrolling
Updated:  5/19/2016
The Mayo Clinic
mi
from
Rochester, MN
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
Status: Enrolling
Updated: 5/19/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child
Helping the Mother With Breast Cancer Support Her Child
Status: Enrolling
Updated:  5/19/2016
Univ of Washington
mi
from
Seattle, WA
Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child
Helping the Mother With Breast Cancer Support Her Child
Status: Enrolling
Updated: 5/19/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Histology of Functional Density in Premenopausal Breast
Pilot Study to Examine Histological Characteristics of Mammographic Density With Molecular Breast Imaging: Part 2 - Premenopausal Women
Status: Enrolling
Updated:  5/19/2016
The Mayo Clinic
mi
from
Rochester, MN
Histology of Functional Density in Premenopausal Breast
Pilot Study to Examine Histological Characteristics of Mammographic Density With Molecular Breast Imaging: Part 2 - Premenopausal Women
Status: Enrolling
Updated: 5/19/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Effects of ASA on Prostate Tissue
In Vivo Molecular Effects of Aspirin on Prostate Tissue
Status: Enrolling
Updated:  5/24/2016
VA Puget Sound Health Care Service
mi
from
Seattle, WA
Effects of ASA on Prostate Tissue
In Vivo Molecular Effects of Aspirin on Prostate Tissue
Status: Enrolling
Updated: 5/24/2016
VA Puget Sound Health Care Service
mi
from
Seattle, WA
Click here to add this to my saved trials
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Outpatient Care Center
mi
from
Indianapolis, IN
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Outpatient Care Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials